List of Excipients in API levalbuterol
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing levalbuterol
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Akorn | XOPENEX | levalbuterol hydrochloride | 17478-171 | HYDROCHLORIC ACID | |
| Akorn | XOPENEX | levalbuterol hydrochloride | 17478-171 | NITROGEN | |
| Akorn | XOPENEX | levalbuterol hydrochloride | 17478-171 | SODIUM CHLORIDE | |
| Akorn | XOPENEX | levalbuterol hydrochloride | 17478-171 | WATER | |
| Akorn | XOPENEX | levalbuterol hydrochloride | 17478-172 | NITROGEN | |
| Akorn | XOPENEX | levalbuterol hydrochloride | 17478-172 | SODIUM CHLORIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing levalbuterol
Detailed excipient profiles for levalbuterol
Excipient focus: ALCOHOL
levalbuterol drug variants containing ALCOHOL
levalbuterol drug variants not containing ALCOHOL
Excipient focus: EDETATE DISODIUM
levalbuterol drug variants containing EDETATE DISODIUM
levalbuterol drug variants not containing EDETATE DISODIUM
Excipient focus: HYDROCHLORIC ACID
levalbuterol drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | levalbuterol | 65862-942 |
| Akorn | levalbuterol hydrochloride | 17478-171 |
| Physicians Total Care Inc | levalbuterol hydrochloride | 54868-6021 |
| >Company | >Ingredient | >NDC |
levalbuterol drug variants not containing HYDROCHLORIC ACID
Excipient focus: NITROGEN
levalbuterol drug variants containing NITROGEN
levalbuterol drug variants not containing NITROGEN
Excipient focus: NORFLURANE
levalbuterol drug variants containing NORFLURANE
levalbuterol drug variants not containing NORFLURANE
Excipient focus: OLEIC ACID
levalbuterol drug variants containing OLEIC ACID
levalbuterol drug variants not containing OLEIC ACID
Excipient focus: SODIUM CHLORIDE
levalbuterol drug variants containing SODIUM CHLORIDE
levalbuterol drug variants not containing SODIUM CHLORIDE
Excipient focus: SULFURIC ACID
levalbuterol drug variants containing SULFURIC ACID
levalbuterol drug variants not containing SULFURIC ACID
Excipient focus: TRISODIUM CITRATE DIHYDRATE
levalbuterol drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | levalbuterol | 0093-4145 |
| Teva Pharmaceuticals USA Inc | levalbuterol | 0093-4147 |
| Proficient Rx LP | levalbuterol | 63187-953 |
| Aurobindo Pharma Limited | levalbuterol | 65862-942 |
| REMEDYREPACK INC | levalbuterol | 70518-2760 |
| >Company | >Ingredient | >NDC |
levalbuterol drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: WATER
levalbuterol drug variants containing WATER
levalbuterol drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
